Genfit S.A. (GNFTF)
OTCMKTS
· Delayed Price · Currency is USD
3.540
+0.100 (2.91%)
At close: Dec 27, 2024
Genfit Employees
Genfit had 159 employees as of December 31, 2023. The number of employees increased by 11 or 7.43% compared to the previous year.
Employees
159
Change (1Y)
11
Growth (1Y)
7.43%
Revenue / Employee
$510,208
Profits / Employee
$141,199
Market Cap
182.54M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
SS Innovations International | 378 |
Endo Inc. | 3,116 |
Northwest Biotherapeutics | 25 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 374 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Genfit News
- 14 days ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2 - Benzinga
- 5 weeks ago - GENFIT Announces Completion of Non-dilutive Royalty Financing Agreement with HCRx and Results of Repurchase Offer to 2025 OCEANEs holders - GlobeNewsWire
- 6 weeks ago - Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs - GlobeNewsWire
- 2 months ago - GENFIT Announces Revenues and Cash Position as of December 31, 2024 - GlobeNewsWire
- 2 months ago - Genfit reports preliminary results of repurchase offer to 2025 OCEANEs holders - Seeking Alpha
- 2 months ago - GENFIT Announces the Preliminary Results of the Repurchase Offer to 2025 OCEANEs holders and the Convening of the 2025 OCEANEs holders' general meeting - GlobeNewsWire
- 2 months ago - GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders - GlobeNewsWire
- 2 months ago - GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025 - GlobeNewsWire